饮用酒雾化吸入治疗戒酒综合征临床分析  

A clinical study of inhalation of alcohol vapor for treatment of alcohol withdrawal symptom

作　　者：孟浩[1] 朱述阳[2] 

机构地区：[1]徐州医学院研究生学院,江苏徐州221004 [2]徐州医学院附属医院呼吸内科,江苏徐州221002

出　　处：《徐州医学院学报》2015年第5期311-313,共3页Acta Academiae Medicinae Xuzhou

摘　　要：目的探讨饮用酒雾化吸入治疗戒酒综合征的疗效。方法选取我院戒酒综合征患者41例，根据治疗方法的不同分为2组，分别以饮用酒雾化吸入或氯硝西泮口服治疗1周；记录患者治疗前后酒精戒断综合征评定量表（AWSS）、酒精戒断状态评定量表（CIWA—Ar）、酒精依赖量表（ADS）评分及不良反应等，比较2组患者的疗效及满意度。结果酒精雾化吸入及氯硝西泮组患者治疗后AWSS、CIWA—Ar及ADS评分均明显下降（P〈0．05），组间比较差异无统计学意义（P〉0．05）；酒精雾化吸入组不良反应少，患者满意度优于氯硝西泮组（P〈0．05）。结论饮用酒雾化吸入可有效治疗戒酒综合征。Objectives To investigate the efficacy of inhalation of alcohol vapor inhalation for treatment of alcohol withdrawal symptom. Methods Clinical data were collected from 41 patients with alcohol withdrawal syndrome （AWS） before retrospective analysis. These patients were divided into two groups who inhaled alcohol vapor or were orally administrated with clonazepam for one week. Then, all patients were scored using the alcohol withdrawal syndrome scale （AWSS）, the clinical institute withdrawal assessment for alcohol （CIWA -Ar） scale, the alcohol dependence scale （ADS） , while adverse reactions were recorded. Both groups were compared for efficacy and the degree of satisfaction. Results After corresponding treatment, both groups produced significantly reduced scores of AWSS, CIWA - Ar and ADS when compared with their scores prior to treatment （P 〈 0.05 ）, in spite of no inter - group statistical difference （ P 〉 0.05 ）. Moreover, patients inhaling alcohol vapor reported less adverse reaction, and become more satisfied than the control （ P 〈 0.05）. Conclusions Inhalation of alcohol vapor is effective for treatment of AWS.

关 键 词：酒精雾化 氯硝西泮 戒酒综合征 

分 类 号：R749.62[医药卫生—神经病学与精神病学]